| AKT | phosphatidylinositol 3-kinase (PI3K)/protein kinase B |
| AMPK | AMP-activated protein kinase |
| CRISP | cysteine-rich secretory protein |
| CSC | cancer stem cell |
| DEN | diethylnitrosamine |
| D-PDMP | D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol |
| DSGG | disialosyl galactosyl globoside |
| EpCAM | epithelial cellular adhesion molecule |
| ER | endoplasmic reticulum |
| ERT | enzyme replacement therapy |
| GBA | glucocerebrosidase |
| GBA3 | glucosylceramidase beta 3 |
| Gb3 | globotriaosylceramide |
| GEMs | glycosphingolipid-enriched microdomains |
| GlcCer | glucosylceramide |
| GM3 | monosialodihexosylganglioside |
| GSLs | glycosphingolipids |
| HCC | Hepatocellular carcinoma |
| HDAC2 | histone deacetylase 2 |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| KO | knockout |
| LCSC | liver cancer stem cell |
| lyso-GlcCer | glucosylsphingosine |
| MAPK | mitogen-activated protein kinase |
| mTOR | mechanistic Target of Rapamycin |
| NASH | non-alcoholic steatohepatitis |
| OE | Overexpression |
| ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 |
| RAF | rapidly accelerated fibrosarcoma |
| S1P | sphingosine-1-phosphate |
| SIN3B | paired amphipathic helix protein |
| SRT | substrate reduction therapy |
| TCGA | The Cancer Genome Atlas |
| UGCG | UDP-glucose ceramide glycosyltransferase |